Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
39
BIO.B Quote, Financials, Valuation and Earnings
Last price:
$298.30
Seasonality move
:
2.25%
Day range:
$310.70 - $310.70
52-week range:
$225.29 - $359.22
Dividend yield:
0%
P/E ratio:
25.83x
P/S ratio:
3.21x
P/B ratio:
1.19x
Volume:
10
Avg. volume:
27
1-year change:
-4.65%
Market cap:
$8B
Revenue:
$2.6B
EPS (TTM):
-$24.31
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.9B | $2.8B | $2.7B | $2.6B | |
| Revenue Growth (YoY) | 10.12% | 14.81% | -4.12% | -4.67% | -3.92% | |
| Cost of Revenues | $1.1B | $1.3B | $1.2B | $1.2B | $1.2B | |
| Gross Profit | $1.4B | $1.7B | $1.6B | $1.4B | $1.4B | |
| Gross Profit Margin | 56.41% | 56.91% | 55.97% | 53.58% | 53.73% | |
| R&D Expenses | $227.8M | $247.3M | $256.8M | $226.9M | $253.9M | |
| Selling, General & Admin | $800.3M | $877.1M | $827.8M | $841.7M | $814M | |
| Other Inc / (Exp) | $4.5B | $4.9B | -$5.2B | -$1.2B | -$2.6B | |
| Operating Expenses | $1B | $1.1B | $1.1B | $1B | $1.1B | |
| Operating Income | $405.2M | $564.7M | $479.3M | $383.8M | $311M | |
| Net Interest Expenses | $21.9M | $1.6M | $38.1M | $49.4M | $48.9M | |
| EBT. Incl. Unusual Items | $4.9B | $5.4B | -$4.7B | -$850.1M | -$2.3B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1B | $1.2B | -$1.1B | -$212.8M | -$498.3M | |
| Net Income to Company | $3.8B | $4.3B | -$3.6B | -$637.3M | -$1.8B | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3.8B | $4.3B | -$3.6B | -$637.3M | -$1.8B | |
| Basic EPS (Cont. Ops) | $127.86 | $142.61 | -$121.79 | -$21.82 | -$65.36 | |
| Diluted EPS (Cont. Ops) | $126.20 | $140.83 | -$121.79 | -$21.82 | -$65.36 | |
| Weighted Average Basic Share | $29.8M | $29.8M | $29.8M | $29.2M | $28.2M | |
| Weighted Average Diluted Share | $30.2M | $30.2M | $29.8M | $29.2M | $28.2M | |
| EBITDA | $580.4M | $741.6M | $656.5M | $576.2M | $503.8M | |
| EBIT | $405.2M | $564.7M | $479.3M | $383.8M | $311M | |
| Revenue (Reported) | $2.5B | $2.9B | $2.8B | $2.7B | $2.6B | |
| Operating Income (Reported) | $405.2M | $564.7M | $479.3M | $383.8M | $311M | |
| Operating Income (Adjusted) | $405.2M | $564.7M | $479.3M | $383.8M | $311M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $747M | $680.8M | $632.1M | $649.7M | $653M | |
| Revenue Growth (YoY) | 15.42% | -8.87% | -7.15% | 2.79% | 0.5% | |
| Cost of Revenues | $309.5M | $307.4M | $296.4M | $293.8M | $310.2M | |
| Gross Profit | $437.5M | $373.4M | $335.7M | $355.9M | $342.8M | |
| Gross Profit Margin | 58.57% | 54.84% | 53.1% | 54.78% | 52.5% | |
| R&D Expenses | $64.3M | $66.8M | $28.7M | $61.1M | $70.6M | |
| Selling, General & Admin | $216.2M | $211.1M | $201.2M | $200.4M | $206.8M | |
| Other Inc / (Exp) | $4.9B | -$298.3M | $41.2M | $793.8M | -- | |
| Operating Expenses | $280.7M | $278.7M | $224.3M | $261.5M | $276.4M | |
| Operating Income | $156.8M | $94.6M | $111.3M | $94.4M | $66.4M | |
| Net Interest Expenses | $426K | $11.7M | $12.4M | $12.2M | $12.3M | |
| EBT. Incl. Unusual Items | $5B | -$207.3M | $137.1M | $861.6M | -$431.1M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.1B | -$44.5M | $30.8M | $208.4M | -$89.2M | |
| Net Income to Company | $3.9B | -$162.8M | $106.3M | $653.2M | -$341.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $3.9B | -$162.8M | $106.3M | $653.2M | -$341.9M | |
| Basic EPS (Cont. Ops) | $131.75 | -$5.48 | $3.65 | $23.37 | -$12.70 | |
| Diluted EPS (Cont. Ops) | $129.96 | -$5.48 | $3.64 | $23.34 | -$12.70 | |
| Weighted Average Basic Share | $29.8M | $29.7M | $29.1M | $27.9M | $26.9M | |
| Weighted Average Diluted Share | $30.2M | $29.7M | $29.2M | $28M | $26.9M | |
| EBITDA | $200.2M | $138.7M | $159.4M | $143.5M | $120.6M | |
| EBIT | $156.8M | $94.6M | $111.3M | $94.4M | $66.4M | |
| Revenue (Reported) | $747M | $680.8M | $632.1M | $649.7M | $653M | |
| Operating Income (Reported) | $156.8M | $94.6M | $111.3M | $94.4M | $66.4M | |
| Operating Income (Adjusted) | $156.8M | $94.6M | $111.3M | $94.4M | $66.4M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $3B | $2.8B | $2.7B | $2.6B | $2.6B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $1.3B | $1.2B | $1.3B | $1.2B | $1.2B | |
| Gross Profit | $1.7B | $1.6B | $1.5B | $1.4B | $1.4B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $252.2M | $259.6M | $229.8M | $246.6M | $259.4M | |
| Selling, General & Admin | $874.6M | $839.7M | $846.8M | $817.2M | $827.3M | |
| Other Inc / (Exp) | $8B | -$8.3B | -$588.6M | -$1.3B | -- | |
| Operating Expenses | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | |
| Operating Income | $618.3M | $494.4M | $397.9M | $344.5M | $287.6M | |
| Net Interest Expenses | $5.9M | $26.8M | $48.8M | $49.1M | $49.1M | |
| EBT. Incl. Unusual Items | $8.6B | -$7.8B | -$187.2M | -$1B | -$842.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.9B | -$1.8B | -$27.9M | -$226.5M | -$166.7M | |
| Net Income to Company | $6.7B | -$6B | -$159.3M | -$778.7M | -$675.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $6.7B | -$6B | -$159.3M | -$778.7M | -$675.9M | |
| Basic EPS (Cont. Ops) | $223.36 | -$201.56 | -$5.73 | -$27.28 | -$24.30 | |
| Diluted EPS (Cont. Ops) | $220.48 | -$201.56 | -$5.85 | -$27.33 | -$24.31 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $793.3M | $685.9M | $599.3M | $541M | $489.9M | |
| EBIT | $618.3M | $494.4M | $397.9M | $344.5M | $287.6M | |
| Revenue (Reported) | $3B | $2.8B | $2.7B | $2.6B | $2.6B | |
| Operating Income (Reported) | $618.3M | $494.4M | $397.9M | $344.5M | $287.6M | |
| Operating Income (Adjusted) | $618.3M | $494.4M | $397.9M | $344.5M | $287.6M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.1B | $2B | $1.9B | $1.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $925M | $900.9M | $925.8M | $860.9M | $891.2M | |
| Gross Profit | $1.3B | $1.2B | $1.1B | $1B | $998.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $186.5M | $190.7M | $163.4M | $184.4M | $191.6M | |
| Selling, General & Admin | $655.4M | $615.6M | $634.6M | $610M | $623.3M | |
| Other Inc / (Exp) | $7.1B | -$6.2B | -$1.6B | -$1.7B | $370.3M | |
| Operating Expenses | $814.4M | $807.1M | $777.1M | $791.4M | $796M | |
| Operating Income | $450.3M | $363.9M | $287.2M | $246.7M | $202.8M | |
| Net Interest Expenses | $1.2M | $26.4M | $37.1M | $36.7M | $36.9M | |
| EBT. Incl. Unusual Items | $7.5B | -$5.8B | -$1.3B | -$1.4B | $66.3M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1.7B | -$1.3B | -$291.5M | -$305.2M | $26.4M | |
| Net Income to Company | $5.8B | -$4.5B | -$987M | -$1.1B | $39.9M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $5.8B | -$4.5B | -$987M | -$1.1B | $39.9M | |
| Basic EPS (Cont. Ops) | $195.24 | -$149.02 | -$33.61 | -$39.43 | $1.26 | |
| Diluted EPS (Cont. Ops) | $192.66 | -$149.02 | -$33.64 | -$39.47 | $1.26 | |
| Weighted Average Basic Share | $89.4M | $89.5M | $88.1M | $84.9M | $82.1M | |
| Weighted Average Diluted Share | $90.6M | $89.5M | $88.3M | $84.9M | $82.1M | |
| EBITDA | $579.7M | $508.1M | $438.5M | $390.2M | $355.8M | |
| EBIT | $450.3M | $363.9M | $287.2M | $246.7M | $202.8M | |
| Revenue (Reported) | $2.2B | $2.1B | $2B | $1.9B | $1.9B | |
| Operating Income (Reported) | $450.3M | $363.9M | $287.2M | $246.7M | $202.8M | |
| Operating Income (Adjusted) | $450.3M | $363.9M | $287.2M | $246.7M | $202.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1B | $875.5M | $1.8B | $1.6B | $1.7B | |
| Short Term Investments | $328.9M | $399.1M | $1.4B | $1.2B | $1.2B | |
| Accounts Receivable, Net | $419.4M | $423.5M | $494.6M | $489M | $452.5M | |
| Inventory | $622.3M | $572.2M | $719.3M | $780.5M | $760M | |
| Prepaid Expenses | $90.6M | $109.1M | $124.2M | $140M | $122.6M | |
| Other Current Assets | $10.9M | $10.1M | $23.6M | $26.1M | $30.7M | |
| Total Current Assets | $2.1B | $2B | $3.2B | $3B | $3B | |
| Property Plant And Equipment | $693.5M | $716.4M | $679.6M | $723.7M | $688.6M | |
| Long-Term Investments | $9.6B | $14.4B | $8.8B | $7.7B | $4.8B | |
| Goodwill | $291.9M | $347.3M | $406.5M | $413.6M | $410.5M | |
| Other Intangibles | $199.5M | $253.9M | $332.1M | $320.5M | $293.6M | |
| Other Long-Term Assets | $86.7M | $104.2M | $94.6M | $94.9M | $101.9M | |
| Total Assets | $13B | $17.8B | $13.5B | $12.3B | $9.4B | |
| Accounts Payable | $139.5M | $141.9M | $134.9M | $142.8M | $122.3M | |
| Accrued Expenses | $222.9M | $277M | $194.8M | $139.9M | $124.2M | |
| Current Portion Of Long-Term Debt | $1.3M | $489K | $465K | $500K | $1.2M | |
| Current Portion Of Capital Lease Obligations | $37M | $36.4M | $36.3M | $40.4M | $41.7M | |
| Other Current Liabilities | $131.1M | $127.9M | $169.6M | $161.6M | $147.2M | |
| Total Current Liabilities | $631.5M | $680.9M | $568.7M | $522.8M | $467.8M | |
| Long-Term Debt | $198.4M | $197M | $1.4B | $1.4B | $1.3B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $3.1B | $4.1B | $3.9B | $3.6B | $2.8B | |
| Common Stock | $3K | $3K | $3K | $3K | -- | |
| Other Common Equity Adj | $282.5M | -$175.6M | -$466.8M | -$336M | -$538.2M | |
| Common Equity | $9.9B | $13.7B | $9.6B | $8.7B | $6.6B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $9.9B | $13.7B | $9.6B | $8.7B | $6.6B | |
| Total Liabilities and Equity | $13B | $17.8B | $13.5B | $12.3B | $9.4B | |
| Cash and Short Terms | $1B | $875.5M | $1.8B | $1.6B | $1.7B | |
| Total Debt | $200.2M | $197.9M | $1.4B | $1.4B | $1.3B | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $1.3B | $1.9B | $1.8B | $1.6B | $1.4B | |
| Short Term Investments | $477.2M | $1.3B | $1.3B | $1.2B | -- | |
| Accounts Receivable, Net | $417.7M | $432.3M | $457.4M | $461.9M | $464.7M | |
| Inventory | $588.9M | $685.9M | $775.8M | $804.3M | $783.2M | |
| Prepaid Expenses | $104.6M | $147.2M | $123.9M | $133.2M | $152M | |
| Other Current Assets | $12.4M | $19.1M | $25.1M | $28.2M | -- | |
| Total Current Assets | $2.5B | $3.1B | $3.1B | $3.1B | $2.8B | |
| Property Plant And Equipment | $680.8M | $632.7M | $711.4M | $719.2M | $720.5M | |
| Long-Term Investments | $16.2B | $7.5B | $7.2B | $6B | $5.1B | |
| Goodwill | $291.9M | $399.6M | $407M | $415.1M | -- | |
| Other Intangibles | $177.1M | $325.1M | $314.2M | $307.3M | -- | |
| Other Long-Term Assets | $106.6M | $101.8M | $98.5M | $103.6M | -- | |
| Total Assets | $20B | $12.1B | $11.9B | $10.6B | $9.7B | |
| Accounts Payable | $136.4M | $142.7M | $111.9M | $122.2M | $128.8M | |
| Accrued Expenses | $243.9M | $192.5M | $154.9M | $146M | -- | |
| Current Portion Of Long-Term Debt | $1.2M | -- | -- | $1.3M | -- | |
| Current Portion Of Capital Lease Obligations | $36.6M | $34.4M | $39.6M | $42.8M | -- | |
| Other Current Liabilities | $177.8M | $171.8M | $147.8M | $142M | -- | |
| Total Current Liabilities | $649.9M | $570.7M | $558.2M | $497.9M | $522.3M | |
| Long-Term Debt | $198.1M | $1.4B | $1.4B | $1.3B | $1.4B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $4.6B | $3.6B | $3.5B | $3.1B | $3B | |
| Common Stock | $3K | $3K | $3K | $3K | -- | |
| Other Common Equity Adj | -$63M | -$845.2M | -$497.6M | -$315.3M | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $15.3B | $8.5B | $8.4B | $7.5B | $6.7B | |
| Total Liabilities and Equity | $20B | $12.1B | $11.9B | $10.6B | $9.7B | |
| Cash and Short Terms | $1.3B | $1.9B | $1.8B | $1.6B | $1.4B | |
| Total Debt | $200.3M | $1.4B | $1.4B | $1.3B | $1.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.8B | $4.3B | -$3.6B | -$637.3M | -$1.8B | |
| Depreciation & Amoritzation | $175.2M | $176.9M | $177.2M | $192.4M | $192.8M | |
| Stock-Based Compensation | $41.6M | $51.2M | $60.9M | $61.3M | $62.3M | |
| Change in Accounts Receivable | -$15M | -$20.4M | -$87.4M | $11.4M | $16.2M | |
| Change in Inventories | -$52.1M | $46.1M | -$158.8M | -$46.3M | $8.5M | |
| Cash From Operations | $575.3M | -$415.4M | $1.4B | $374.9M | $454.6M | |
| Capital Expenditures | $98.9M | $133.7M | $114.2M | $156.7M | $165.6M | |
| Cash Acquisitions | $96.7M | $125.5M | $100.7M | -- | -- | |
| Cash From Investing | -$60.3M | -$797.4M | -$1.2B | $20.2M | -$160.2M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $1.2B | -- | -- | |
| Long-Term Debt Repaid | -$426.9M | -$3M | -$500K | -$500K | -$400K | |
| Repurchase of Common Stock | $100M | $50M | $215.7M | $428.7M | $203.6M | |
| Other Financing Activities | -$16.3M | -$23M | -$14M | -$14.9M | -$34M | |
| Cash From Financing | -$523M | -$55.4M | $973.6M | -$425.6M | -$218.2M | |
| Beginning Cash (CF) | $666.2M | $470.8M | $434.2M | $404M | $489.5M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $4.5M | -$196M | -$36.6M | -$30.2M | $85.4M | |
| Ending Cash (CF) | $683.1M | $262.2M | $400.6M | $374.1M | $584.1M | |
| Levered Free Cash Flow | $476.4M | -$549.2M | $1.3B | $218.3M | $289M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3.9B | -$162.8M | $106.3M | $653.2M | -$341.9M | |
| Depreciation & Amoritzation | $43.4M | $44.1M | $48.1M | $49.1M | $54.2M | |
| Stock-Based Compensation | $13.1M | $15.7M | $15.9M | $15.6M | $14.9M | |
| Change in Accounts Receivable | -$23.7M | $1.3M | $26.4M | -$7.4M | $4.2M | |
| Change in Inventories | $13.9M | -$48.3M | -$6.4M | $15.2M | $13.6M | |
| Cash From Operations | $230.4M | -$1.4B | -$293.9M | $163.6M | $120.9M | |
| Capital Expenditures | $34.6M | $27.6M | $44.1M | $40.2M | $31.7M | |
| Cash Acquisitions | -- | $100.7M | -- | -- | $1.8M | |
| Cash From Investing | -$81.4M | -$88.4M | -$9.5M | -$55.6M | -$43M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$122K | -$113K | -$118K | -$59K | -- | |
| Repurchase of Common Stock | -- | -- | $21.3M | $97.8M | $53.4M | |
| Other Financing Activities | -$21.8M | -$13.4M | -$9.8M | -$3.1M | -- | |
| Cash From Financing | -$15.6M | -$8.8M | -$26.6M | -$96M | -$52.5M | |
| Beginning Cash (CF) | $863.7M | $518M | $457.9M | $411.8M | $397.8M | |
| Foreign Exchange Rate Adjustment | -$6.1M | $7.5M | $6.2M | -$7.5M | $1.1M | |
| Additions / Reductions | $127.4M | -$78.7M | $67.8M | $4.5M | $26.5M | |
| Ending Cash (CF) | $985M | $446.8M | $532M | $408.7M | $425.4M | |
| Levered Free Cash Flow | $195.7M | -$1.4B | -$338M | $123.4M | $89.2M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $6.7B | -$6B | -$159.3M | -$778.7M | -$675.9M | |
| Depreciation & Amoritzation | $175M | $179.1M | $185M | $196.5M | $202.3M | |
| Stock-Based Compensation | $48.5M | $57.8M | $63.2M | $62.1M | $58.5M | |
| Change in Accounts Receivable | -$16.2M | -$54.1M | -$11.3M | $5.4M | $6.3M | |
| Change in Inventories | $59.6M | -$132.7M | -$69.9M | -$600K | $41.8M | |
| Cash From Operations | $1.6B | -$799.2M | $1.6B | $411.5M | $491.5M | |
| Capital Expenditures | $116.7M | $134.2M | $150.6M | $164.9M | $154.7M | |
| Cash Acquisitions | -- | $226.3M | -- | -- | $218.5M | |
| Cash From Investing | -$280.1M | -$1.7B | -$110.5M | -$57.5M | -$186M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1.2B | -- | -- | -- | |
| Long-Term Debt Repaid | -$426.8M | -$1.7M | -$482K | -$510K | -- | |
| Repurchase of Common Stock | $50M | $125M | $319.4M | $403.6M | $295.5M | |
| Other Financing Activities | -- | -- | -- | -$8.7M | -- | |
| Cash From Financing | -$481.9M | $1.1B | -$311.6M | -$392.6M | -$312.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $19.4M | -$346.3M | -$59.9M | -$46.1M | -$14M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $1.5B | -$933.4M | $1.5B | $246.5M | $336.8M | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $5.8B | -$4.5B | -$987M | -$1.1B | $39.9M | |
| Depreciation & Amoritzation | $129.4M | $131.6M | $139.4M | $143.5M | $153M | |
| Stock-Based Compensation | $36.2M | $42.8M | $45.1M | $45.9M | $42.1M | |
| Change in Accounts Receivable | -$10.8M | -$44.5M | $31.6M | $25.6M | $15.7M | |
| Change in Inventories | $28.2M | -$150.6M | -$61.7M | -$16M | $17.3M | |
| Cash From Operations | $498.6M | $114.8M | $293.9M | $330.4M | $367.3M | |
| Capital Expenditures | $77.6M | $78M | $114.4M | $122.7M | $111.8M | |
| Cash Acquisitions | -- | $100.7M | -- | -- | $218.5M | |
| Cash From Investing | -$230M | -$1.1B | -$52M | -$129.7M | -$155.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $1.2B | -- | -- | -- | |
| Long-Term Debt Repaid | -$1.6M | -$367K | -$349K | -$359K | -$300K | |
| Repurchase of Common Stock | $50M | $125M | $228.7M | $203.6M | $295.5M | |
| Other Financing Activities | -$22.9M | -$13.9M | -$10.1M | -$3.9M | -$100K | |
| Cash From Financing | -$60.1M | $1.1B | -$225M | -$191.9M | -$286.5M | |
| Beginning Cash (CF) | $2.3B | $1.9B | $1.3B | $1.3B | $1.3B | |
| Foreign Exchange Rate Adjustment | -$11.2M | $21.2M | $6.9M | -$1M | -$16.9M | |
| Additions / Reductions | $197.4M | $47.1M | $23.8M | $7.8M | -$91.6M | |
| Ending Cash (CF) | $2.5B | $2B | $1.3B | $1.3B | $1.2B | |
| Levered Free Cash Flow | $421M | $36.8M | $179.5M | $207.7M | $255.5M | |
Related Companies
Get BIO.B Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BIO.B
Sector
P/E ratio
25.83x
23.89x
PEG ratio
-0.01x
-0.01x
P/B ratio
1.19x
1.81x
Price / LTM sales
3.21x
1.59x
Growth Metrics
BIO.B
Sector
Revenue growth
0.5%
4.62%
Earnings growth
-154.41%
11.06%
Revenue (5-year growth)
2.11%
6.5%
Earnings forecast
--
-$0.21
Profitability
BIO.B
Sector
Profitability FY 2024
$1.4B
$3.6M
Return on invested capital
-8.14%
-31.84%
Return on assets
-6.84%
-27.96%
Return on equity
-9.77%
-37.63%
Earnings Date
Last Earnings Date
Oct
29
Next Earnings Date
Feb
12
Estimated Next Earnings Date
Jan
28
Balance Sheet
BIO.B
Sector
Total cash
$1.4B
$26.4M
Short term investments
$1.2B
$25.7M
Total assets
$9.4B
$76.9M
Long term debt
$1.4B
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
